Abstract
Background
Utilization of percutaneous needle biopsy (PNB) has been proposed as a quality measure of breast cancer care. We evaluated rates and reasons for failure of patients undergoing PNB as the initial diagnostic procedure for evaluation of breast pathology.
Methods
We performed a retrospective review of sequential patients undergoing image-guided PNB and open surgical excisional breast biopsies from January 2006 to July 2009 at our institution. Factors associated with failure to undergo a percutaneous approach were analyzed.
Results
During the study period, 1196 breast biopsies were performed; 87 (7.3%) were open surgical biopsies, and 1109 (92.7%) were PNB. Imaging used for percutaneous guidance or needle localization was ultrasound in 58.9%, mammogram in 40.0%, and magnetic resonance imaging (MRI) in 0.9%. Open surgical excisional biopsy was associated with mammographic guidance (P < .001), location in the central or lower inner quadrant of the breast (P = .002), BIRADS score of 1 or 6 (P < .001), or calcifications as target (P < .001). There were no differences in rates of PNB by age, size of lesion, or breast density. Reasons for failure of PNB were technical (calcifications not visualized, proximity to implant, etc.) in 86.2% of cases. No reason was documented in 10.3%, and 3.4% of patients refused a percutaneous approach.
Conclusions
The majority of patients in this series underwent PNB as an initial diagnostic approach. Most percutaneous failures are due to technical reasons. PNB rates are a reasonable quality measure in breast cancer care. Documentation of failure to meet this benchmark should be stringently monitored.
Similar content being viewed by others
References
Brenner RJ, Bassett LW, Fajardo LL, Dershaw DD, Evans WP III, Hunt R, et al. Stereotactic core-needle breast biopsy: a multi-institutional prospective trial. Radiology. 2001;218:866–72.
Lee CH, Egglin TK, Philpotts L, Mainiero MB, Tocino I. Cost-effectiveness of stereotactic core needle biopsy: analysis by means of mammographic findings. Radiology. 1997;202:849–54.
Bruening W, Fontanarosa J, Tipton K, Treadwell JR, Launders J, Schoelles K. Systematic review: comparative effectiveness of core-needle and open surgical biopsy to diagnose breast lesions. Ann Intern Med. 152:238–46.
Verkooijen HM, Peeters PH, Buskens E, Koot VC, Borel Rinkes IH, Mali WP, et al. Diagnostic accuracy of large-core needle biopsy for nonpalpable breast disease: a meta-analysis. Br J Cancer. 2000;82:1017–21.
http://accreditedbreastcenters.org/standards/2009standardsmanual.pdf. Accessed 15 June 2010.
Friese CR, Neville BA, Edge SB, Hassett MJ, Earle CC. Breast biopsy patterns and outcomes in surveillance, epidemiology, and end results—medicare data. Cancer. 2009;115:716–24.
Philpotts LE, Lee CH, Horvath LJ, Tocino I. Canceled stereotactic core-needle biopsy of the breast: analysis of 89 cases. Radiology. 1997;205:423–8.
Verkooijen HM. Diagnostic accuracy of stereotactic large-core needle biopsy for nonpalpable breast disease: results of a multicenter prospective study with 95% surgical confirmation. Int J Cancer. 2002;99:853–9.
Clarke-Pearson EM, Jacobson AF, Boolbol SK, Leitman IM, Friedmann P, Lavarias V, et al. Quality assurance initiative at one institution for minimally invasive breast biopsy as the initial diagnostic technique. J Am Coll Surg. 2009;208:75–8.
Silverstein MJ, Recht A, Lagios MD, Allred DC, Harms SE, Holland R, et al. Image-detected breast cancer: state-of-the-art diagnosis and treatment. J Am Coll Surg. 2009;209:504–20.
http://www.facs.org/cancer/qualitymeasures.html. Accessed 15 June 2010.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Olaya, W., Bae, W., Wong, J. et al. Are Percutaneous Biopsy Rates a Reasonable Quality Measure in Breast Cancer Management?. Ann Surg Oncol 17 (Suppl 3), 268–272 (2010). https://doi.org/10.1245/s10434-010-1249-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-010-1249-z